Is 5 ml of Nitrofurantoin (25mg/5ml) every 6 hours for 7 days an appropriate treatment for a 38-pound female with a urinary tract infection (UTI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nitrofurantoin Dosing for a 38-pound Female with UTI

The recommended dose of nitrofurantoin for a 38-pound (17.2 kg) female with UTI is 25-50 mg every 6 hours for 5 days, making the prescribed dose of 5 ml (25 mg) every 6 hours for 7 days appropriate but potentially longer than necessary. 1

Dosing Considerations

  • Nitrofurantoin is a first-line agent for uncomplicated UTIs, with macrocrystalline formulations typically dosed at 50-100 mg four times daily for adults 1
  • For pediatric patients, the dose should be adjusted based on weight:
    • The typical pediatric dose is 5-7 mg/kg/day divided every 6 hours 1
    • For a 38-pound (17.2 kg) child, this would equate to approximately 21-30 mg every 6 hours
    • The prescribed dose of 25 mg (5 ml of 25 mg/5 ml suspension) every 6 hours falls within this appropriate range 1

Duration of Therapy

  • Current guidelines recommend a 5-day course of nitrofurantoin for uncomplicated UTIs 1
  • The prescribed 7-day duration is slightly longer than the recommended 5 days but remains within reasonable limits 1
  • Longer courses (>5 days) should generally be avoided to prevent adverse effects and antimicrobial resistance 1

Efficacy and Safety

  • Nitrofurantoin has maintained good activity against common UTI pathogens including Escherichia coli, Staphylococcus saprophyticus, and Enterococcus species despite decades of use 2
  • It achieves high urinary concentrations while maintaining low serum levels, making it ideal for lower UTIs 3
  • Short-term therapy (5 days) has demonstrated good efficacy and tolerability comparable to other standard treatments 2, 4

Important Considerations

  • Ensure adequate renal function, as nitrofurantoin requires sufficient kidney function to achieve therapeutic concentrations in urine 5
  • Nitrofurantoin is contraindicated in the last trimester of pregnancy and in patients with significant renal impairment 2
  • Common side effects include nausea, headache, and flatulence; serious adverse effects like pulmonary reactions and polyneuropathy are rare with short-term use 2, 3
  • Patients should be advised to take nitrofurantoin with food to improve absorption and reduce gastrointestinal side effects 1

Follow-up Recommendations

  • If symptoms persist beyond treatment completion or recur within 2 weeks, urine culture with antimicrobial susceptibility testing should be performed 1
  • Routine post-treatment urinalysis or urine cultures are not indicated for asymptomatic patients 1
  • For recurrent UTIs, consider preventive strategies such as increased fluid intake, proper hygiene, and possibly prophylactic antibiotics if infections are frequent 1

In conclusion, the prescribed regimen of nitrofurantoin 25 mg/5 ml, 5 ml every 6 hours is appropriate for the patient's weight, though a 5-day course would be sufficient according to current guidelines 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Nitrofurantoin--clinical relevance in uncomplicated urinary tract infections].

Medizinische Monatsschrift fur Pharmazeuten, 2014

Research

Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women.

The British journal of general practice : the journal of the Royal College of General Practitioners, 2002

Research

Kidney function and the use of nitrofurantoin to treat urinary tract infections in older women.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.